Live Well, Live Long

Learn whats going on in the world of cutting edge health news

Sign up for Health News

As a product formulator and consultant specializing in evidence-based nutritional formulations, I’m always evaluating botanicals that combine traditional use with modern scientific validation.
One that continues to stand out is Jiaogulan, often called the “Immortality Herb.”

Rich in over 80 gypenosides—bioactive compounds structurally similar to ginsenosides in Panax ginseng—Jiaogulan offers multiple clinically relevant benefits:

✅ Cardiovascular Support – helps regulate blood pressure, improve endothelial function, and balance lipid levels.
✅ Metabolic Optimization – supports insulin sensitivity and glucose control.
✅ Adaptogenic Activity – enhances the body’s resilience to stress while promoting mental and physical stamina.
✅ Antioxidant & Anti-Inflammatory Effects – protects against oxidative damage and supports healthy aging.
✅ Immune Modulation – can help strengthen immune defenses while calming an overactive immune response promoting balance rather than overstimulation.
✅ Respiratory Support – used to enhance lung function and oxygen uptake, benefiting endurance and recovery.

Do you have any personal experience with Jiaogulan?

From a formulation perspective, Jiaogulan pairs exceptionally well with synergistic ingredients such as:

❇️ Cordyceps or Rhodiola for energy and stress resilience
❇️ Berberine, Bitter Melon, Cinnamon extract for metabolic formulations
❇️ CoQ10, Hawthorn, NAC in cardiovascular and longevity blends

Its versatility and strong safety profile make it an outstanding candidate for next-generation adaptogenic, longevity, and cardiometabolic formulations.

If you’re a nutraceutical brand, healthcare company, or practitioner developing products in these areas, I help design and optimize formulations backed by science, efficacy, and market differentiation.

Let’s collaborate to bring advanced, evidence-informed products to life.

health #healthcare #herbs #medicinalherbs #functionalmedicine #naturopathicmedicine #integrativemedicine #nutraceuticals #healthspan #lifespan #naturalmedicine #herbalmedicine #nutrition #naturalhealth #jiaogulan

In the evolving field of nutraceutical science, Magnolia officinalis continues to stand out — thanks to two key compounds: magnolol and honokiol.
These biphenolic molecules bridge neuroscience, inflammation, and metabolic regulation, offering a broad therapeutic spectrum that’s rare among botanical actives.

✅Neuroprotective & Cognitive Support

– Cross the blood–brain barrier
– Modulate GABA_A receptors → calm, focus, and sleep
– Reduce neuroinflammation & oxidative stress
– Support neuroprotection and healthy cognition

✅Cardiometabolic Support

– Activate AMPK → improved insulin sensitivity & lipid metabolism
– Reduce inflammatory cytokines
– Enhance endothelial and vascular function

✅Systemic Anti-Inflammatory & Antioxidant Effects

– Inhibit NF-κB and MAPK pathways
– Reduce oxidative and inflammatory stress across multiple systems

❇️Emerging Research Areas

– Oncology: Inhibits tumor growth & angiogenesis via PI3K/Akt and STAT3

– Gut & Liver: Supports microbiome balance and reduces endotoxemia

– Microbial Defense: Active against H. pylori and Candida albicans

As a product formulator, I find magnolol and honokiol particularly fascinating for their dual neuro-metabolic and anti-inflammatory synergy — bridging stress, inflammation, and metabolic imbalance, the underlying triad in many chronic conditions.

These compounds are now finding new relevance in precision nutraceutical and longevity formulations.

Key references:

Zhao et al., Frontiers in Pharmacology (2020)
Li et al., Phytomedicine (2018)
Fang et al., Biochem Pharmacol (2015)
Chen et al., J Ethnopharmacol (2020)


Rob Lamberton
Product Formulator | Consultant in Functional & Regenerative Health Innovation

Let’s connect if your company or clinic is exploring bioactive compounds and advanced nutraceutical formulations for brain, metabolic, or longevity applications.

#depression #anxiety #anxiolytic #health #healthcare #herbs #medicinalherbs #functionalmedicine #naturopathicmedicine #integrativemedicine #nutraceuticals #healthspan #lifespan #naturalmedicine #herbalmedicine #nutrition #naturalhealth

Ivermectin shown to have yet another significant potential benefit!

Content paraphrased from a Focus Points – Courageous Discourse Substack article by Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

https://mcculloughfnd.org

Landmark preclinical study shows intranasal ivermectin nanocapsules safely shrink glioblastoma in animal models at doses lower than the approved human antiparasitic dose.

Tumor Size Reduced by 70%

After just 10 days of treatment:

✅Control tumors averaged 254 mm³
✅IVM-NC tumors averaged only 79 mm³ — a 70% reduction in size, confirmed by histopathology
✅Non-encapsulated (free) ivermectin — given the same intranasal route — had no measurable effect

Zero Detectable Toxicity
At the same time, the nano-formulated ivermectin showed no adverse effects:

✳️No changes in body weight, liver, or kidney markers
✳️No lung inflammation, hemorrhage, or edema
✳️No cytotoxicity in normal fibroblast cell lines
✳️Even at repeated daily doses, the treatment remained completely well-tolerated.
✳️By contrast, the non-nano (free) ivermectin and silica nanoparticle formulations both caused tissue irritation and cell death at higher concentrations.

✅ These findings align with ivermectin’s 14 distinct anti-cancer mechanisms summarized by Yuwen et al., encompassing inhibition of oncogenic signaling (YAP1, Wnt–TCF, Akt/mTOR, EGFR/NF-κB, MAPK), mitochondrial and oxidative-stress induction, ion-channel modulation, and suppression of both cancer stem cells and the epithelial–mesenchymal transition (EMT).

✅ By hitting multiple hallmarks of cancer simultaneously — proliferation, metabolism, invasion, and survival — ivermectin appears to function as a multi-targeted anti-tumor agent. In glioblastoma, these converging effects explain the 70% tumor-volume reduction observed with intranasal nano-ivermectin, achieved at doses below standard antiparasitic levels and without toxicity.

✅ Clinical translation in humans is urgently needed. Encouragingly, this effort may already be underway. On September 24, 2025, Governor Ron DeSantis and First Lady Casey DeSantis announced a $60 million funding opportunity through the Florida Cancer Innovation Fund, prioritizing translational cancer research, short-duration clinical trials, and the repurposing of safe, generic drugs such as ivermectin for cancer treatment.

As a nutritional supplement formulator and consultant, I’m always searching for ingredients that actively modulate the biological pathways of aging

One of the most impressive compounds I’ve worked with is L-Ergothioneine (ERG) — an amino acid found in mushrooms 🍄 that may be among the most powerful longevity molecules discovered so far

We actually have a dedicated transporter (OCTN1) to absorb and retain it — meaning it’s biologically essential for long-term cellular protection and repair

🧬 How L-Ergothioneine Impacts Longevity and Cellular Health

L-Ergothioneine can help increase both lifespan (in animal models) and healthspan, creating a foundation for cellular resilience and genomic integrity — the #1 predictor of longevity

💠 Genomic Stability & DNA Repair

• Protects and repairs both nuclear and mitochondrial DNA
• Prevents telomere shortening
• Repairs aging-dependent accumulation of point mutations in the mtDNA control region
• Eliminates DNA-damaging acids hypobromous and hypochlorous

💠 Mitochondrial & Metabolic Optimization

• Increases mitochondrial and metabolic activity
• Prevents mitochondrial dysfunction and supports efficient ATP production
• Increases cell viability by up to 45%

💠 Superior Antioxidant Power

• Eliminates all free radicals 3,435% more effectively than glutathione
• Inhibits cell membrane damage 270% better than CoQ10
• Neutralizes singlet oxygen up to 7,500% better than any known antioxidant
• Provides sustained antioxidant protection for up to 30 days

💠 Systemic Anti-Aging Benefits

• Supports cognition, cardiovascular health, and organ vitality
• Helps prevent sarcopenia and macular degeneration
• Reverses UV and sun damage by repairing and protecting skin DNA and mtDNA

ERG doesn’t simply slow aging — it addresses its root biological mechanisms, restoring cellular function from the inside out

⚗️ Formulation Insight

In advanced nutraceutical formulations, L-Ergothioneine pairs synergistically with:
🔹 Ingredients targeting mitochondrial biogenesis and energy metabolism
🔹 NAD+ Precursors → For NAD⁺ restoration and DNA repair
🔹 Compounds which activate NRF2 activation and cellular detox pathways

Together, these ingredients form the core of next-generation longevity formulations — designed to extend not just life, but quality of life

If your brand or clinic is exploring science-based formulation strategies for longevity, cognition, or metabolic vitality, reach out to me

Let’s connect to transform cutting-edge longevity science into real-world, market-ready innovation

Rob Lamberton, BSc, FNTP, FDN-P
🧪 Nutritional Supplement Formulator | Consultant | Integrative Health Strategist

Helping brands and practitioners develop evidence-based, biologically intelligent nutraceutical formulations

#longevity #nutraceuticals #healthyliving #formulationscience #healthspan #lifespan #formulationscience #ergothioneine #health #nutritionalsupplements #healthcare

Here are two resources I want share on this topic have provided me with some clarity:

– An article by Peter McCullough MD MPH

Peter is a highly respected cardiologist who has been quite vocal about the pandemic and it’s after effects ever since it started 

– A podcast by Peter Attia MD which reviews in depth some key studies on this topic – https://tinyurl.tools/e1b95f87

The Takeaway?

Acetaminophen may have a minor/negligible impact on the development of ASD – Autism Spectrum Disorder – or even none 

Following is the article by Peter McCullough

Confounded Association Between Prenatal Tylenol and Childhood Neuropsychiatric Disorders

Large, Conclusive Swedish Study Finds Relationship, Demonstrates Lack of Independence

PETER A. MCCULLOUGH, MD, MPH

Before the recent HHS press briefing on autism, there was little or no discussion on mainstream, social, or Substack media on acetaminophen use during pregnancy. Many did not know Tylenol is one of many drugs implicated.

An AI search found at least thirty drugs used during pregnancy “linked” to neuropsychiatric problems later on in the child.

There are numerous prenatal drugs and substances that have been associated with increased risk of childhood neuropsychiatric or neurodevelopmental disorders (such as autism spectrum disorder, ADHD, intellectual disability, anxiety, depression, behavioral problems, or cognitive deficits) in the scientific literature. Based on a synthesis of peer-reviewed sources (including systematic reviews, cohort studies, and meta-analyses from PubMed, JAMA, BMJ, and other databases), at least 30 specific drugs have been associated with these risks to varying degrees. Citations are rendered inline where direct sources are available.

Anticonvulsants/Antiseizure Medications (5+ drugs) These are commonly linked to neurodevelopmental risks, especially autism and intellectual disability, due to interference with brain development.

  • Valproic acid/valproate: Strongly associated with ASD (up to 7-fold increased risk), lower IQ, and behavioral disorders.jamanetwork.com +3
  • Carbamazepine: Neural tube defects and potential cognitive delays.womensmentalhealth.org
  • Phenytoin: Linked to developmental delays and cognitive deficits (though evidence is weaker than for valproate).pmc.ncbi.nlm.nih.gov
  • Topiramate: Increased risk of ASD and intellectual disability.med.stanford.edu
  • Lamotrigine: Mixed evidence; some studies show weak links to oral clefts or learning difficulties, but often considered lower-risk.aafp.org +1

Antidepressants (15+ drugs) Prenatal exposure, especially in the first trimester, has been linked to ASD, ADHD, altered brain development, and behavioral issues, though evidence is conflicting and often tied to underlying maternal depression.

  • SSRIs (selective serotonin reuptake inhibitors) as a class: Increased ASD risk (up to 2-fold) and altered pain response or stress axis function.womensmentalhealth.org
    • Fluoxetine: Autism-like behaviors, lifelong behavioral abnormalities, altered serotonin function.
    • Paroxetine: Attention problems, aggression, hyperactivity.
    • Sertraline: Cognitive and behavioral changes.
    • Citalopram: Neonatal distress with potential long-term behavioral effects.
    • Escitalopram: Musculoskeletal defects and psychomotor delays.
  • TCAs (tricyclic antidepressants) as a class: Neonatal syndrome, long-term behavioral changes (e.g., altered social interaction, cognition).
    • Amitriptyline: Developmental delays, central nervous system effects.
    • Clomipramine: Autism-like responses, reduced anxiety in models.
    • Desipramine: Altered behavioral responsiveness.
    • Imipramine: Behavioral changes, altered brain histology.
    • Nortriptyline: Decreased body weight and potential developmental effects (animal models).
    • Trimipramine: Major abnormalities (animal models).
  • SNRIs (serotonin-norepinephrine reuptake inhibitors): Similar to SSRIs; disrupted behaviors.
    • Venlafaxine: Decreased exploratory/social behaviors.
  • Atypical antidepressants: Anxiety-like behaviors.
    • Bupropion: Increased anxiety, stress vulnerability, substance sensitivity.
    • Trazodone: Decreased exploratory/social behaviors.
  • MAOIs (monoamine oxidase inhibitors): Limited data, but linked to ASD.
    • Selegiline: Increased ASD risk.

Antipsychotics (7+ drugs) Associated with neurodevelopmental disorders and learning difficulties, though evidence is emerging and often for neonatal withdrawal rather than long-term effects.

  • Typical antipsychotics as a class: Potential congenital malformations.
    • Haloperidol: Teratogenic risks low, but neonatal effects.
    • Perphenazine: Malformations (low-potency agents).
    • Trifluoperazine: Similar to above.
  • Atypical antipsychotics as a class: Risk of specific neurodevelopmental disorders; neonatal extrapyramidal signs or withdrawal.sciencedirect.com
    • Olanzapine: No major malformations, but neonatal complications.
    • Risperidone: Similar neonatal risks.
    • Quetiapine: Obstetrical/neonatal complications.
    • Clozapine: Limited data; potential malformations.
    • Aripiprazole: Limited data.

Opioids (4+ drugs)Linked to lower cognitive/motor skills, ADHD, and behavioral disorders, though not always substantial increases.  bmj.com +4

  • Methadone: Lower mental development, neurodev impairment.
  • Morphine: Altered stress responses, anxiety-like behaviors.
  • Oxycodone: Similar to morphine; long-term morbidity.
  • Buprenorphine: Neonatal withdrawal, behavioral changes.

Other Medications (3+ drugs)

  • Acetaminophen: Increased risk of NDDs (e.g., autism, ADHD) and other neuropsychiatric disorders.ehjournal.biomedcentral.com +1
  • Benzodiazepines (class): Possible increased risk of learning/neuropsychiatric disorders, cleft lip/palate (weak long-term data).womensmentalhealth.org
  • Synthetic glucocorticoids (e.g., dexamethasone, betamethasone): Attention problems, executive dysfunction, cortical thinning.pmc.ncbi.nlm.nih.gov

As an epidemiologist and a long-standing journal editor, I have become skilled at determining and examining the best and most conclusive sources of evidence among many publications on a topic. The reported link between prenatal acetaminophen use and the development of neuropsychiatric disorders several years later in the child is best evaluated by Ahlqvist et al, JAMA 2024

By Rob Lamberton, BSc, FNTP, FDN-P
Functional Medicine Practitioner & Product Formulator


Most people already know that soda isn’t exactly a wellness beverage. But far fewer understand that one particular ingredient — phosphoric acid — may be doing far more harm than the sugar itself.

Used in many cola drinks for its sharp, tangy flavor and as a preservative to inhibit bacterial growth, phosphoric acid has been linked to a range of negative effects on bone, kidney, heart, and dental health.

Let’s look at what the science reveals — and why reducing your exposure could support long-term health and vitality.


🦴 1. Bone Health: The Silent Calcium Drain

Phosphoric acid increases urinary calcium loss, creating a calcium deficit that your body compensates for by drawing calcium from the bones.

Over time, this can lead to bone demineralization, lower bone density, and an elevated risk of osteopenia and osteoporosis — particularly in women.

👉 In the Framingham Osteoporosis Study, women who consumed cola beverages daily had significantly lower bone mineral density compared to non-cola drinkers — even when calcium and vitamin D intake were adequate.

Tucker KL et al., Am J Clin Nutr. 2006;84(4):936–942.


💧 2. Kidney Health: Acid Load and Stone Formation

Phosphoric acid contributes to urine acidification, which can promote the formation of uric acid and phosphate-based kidney stones.

Excess dietary phosphate may also cause renal tubular injury and accelerate renal aging and fibrosis, even in those without existing kidney disease.

Sullivan CM et al., Clin J Am Soc Nephrol. 2017;12(12):2034–2043.

For individuals with reduced kidney function or metabolic issues, this acid load can further compromise the body’s ability to regulate phosphate balance.


❤️ 3. Cardiovascular Impact: Accelerated Vascular Aging

Elevated serum phosphate levels have been associated with vascular calcification, arterial stiffness, and endothelial dysfunction — all precursors to cardiovascular disease.

Even modest increases in phosphate within the high-normal range are linked to greater all-cause and cardiovascular mortality.

Ellam TJ, Chico TJ. Clin Sci (Lond). 2012;122(10):397–407.

Essentially, excessive phosphate may “age” the arteries from the inside out, contributing to premature cardiovascular decline.


😬 4. Dental Health: Erosion Without Sugar

Sugar isn’t the only dental villain. Phosphoric acid is highly erosive to tooth enamel, stripping away minerals that protect against decay.

Even sugar-free sodas can degrade enamel due to their acidity. Over time, this leads to tooth sensitivity, cavities, and enamel thinning.

Barbosa CS et al., J Clin Pediatr Dent. 2020;44(1):22–26.


⚖️ 5. Acid-Base Imbalance and Mineral Depletion

Your body works hard to maintain a stable pH balance. Regular consumption of acidic beverages like soda can lead to low-grade metabolic acidosis, prompting the body to buffer acid by drawing alkaline minerals such as calcium and magnesium from bones and muscles.

This process can contribute to mineral depletion, fatigue, and musculoskeletal discomfort over time.

Bushinsky DA, J Nephrol. 2017;30(2):215–221.


🍭 6. Nutrient Displacement and Metabolic Stress

Every can of soda replaces a more nourishing beverage such as water, mineral water, or herbal tea. The result is reduced intake of key nutrients — and an increase in sugar, caffeine, and phosphate, which together amplify insulin resistance, metabolic syndrome, and weight gain.

Vartanian LR et al., Am J Public Health. 2007;97(4):667–675.


💡 The Takeaway

Phosphoric acid isn’t just a flavor enhancer — it’s a biochemically active compound with real physiological effects.

Even diet sodas, though free from sugar, can still:
✅ Weaken bones
✅ Stress kidneys
✅ Promote vascular calcification
✅ Erode dental enamel

Over time, these effects add up, contributing to premature aging of multiple organ systems.

If you’re looking to protect your long-term health and longevity, start by replacing soda with health-promoting alternatives:

💧 Mineral-rich sparkling water
🍋 Water with lemon or trace minerals
🌿 Herbal infusions or adaptogenic teas

Your bones, kidneys, teeth, and heart will thank you.


📚 References

  1. Tucker KL, et al. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women. Am J Clin Nutr. 2006;84(4):936–942.
  2. Sullivan CM, et al. Phosphate toxicity in chronic kidney disease: new insights. Clin J Am Soc Nephrol. 2017;12(12):2034–2043.
  3. Ellam TJ, Chico TJ. Phosphate: the silent killer? Clin Sci (Lond). 2012;122(10):397–407.
  4. Barbosa CS, et al. Dental enamel erosion by acidic soft drinks: an in vitro study. J Clin Pediatr Dent. 2020;44(1):22–26.
  5. Bushinsky DA. Acid-base imbalance and bone disease. J Nephrol. 2017;30(2):215–221.
  6. Vartanian LR, et al. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007;97(4):667–675.

✳️ About Rob Lamberton

Rob Lamberton, BSc, FNTP, FDN-P, is a Functional Medicine Practitioner, Health Consultant, and Product Formulator specializing in longevity and regenerative health solutions.
Through his work, Rob helps individuals and health companies develop science-based strategies that optimize human performance and healthspan.

👉 Learn more at www.roblamberton.com